ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Racial Differences in Transplant and Waitlist Mortality Rates Among HIV+ Kidney Transplant Candidates

    J. Locke,1 S. Gustafson,2 C. Durand,3 J. Snyder,2 B. Shelton,1 R. Reed,1 P. MacLennan,1 S. Mehta,1 A. Nellore,1 D. Segev.2,3

    1University of Alabama, Birmingham, Birmingham, AL; 2SRTR, MMRF, Minneapolis, MN; 3Johns Hopkins Univerity, Baltimore, MD.

    Kidney transplant (KT) is now a viable option for select HIV+ end-stage renal disease patients. As OPTN does not collect HIV status at waitlisting, no…
  • 2015 American Transplant Congress

    Tolerant Kidney Transplant Patients Display B Cells With Regulatory Properties

    S. Brouard,1,2 M. Chesneau,1,3 L. Michel,1,2,3 E. Dugast,1,3 A. Chenouard,1,3 A. Pallier,1 D. Baron,1,3 J. Durand,1,3 F. Braza,1,3 P. Guerif,2 D.-A. Laplaud,1,2,3 J.-P. Soulillou,1,2,3 M. Giral,1,2,3 N. Degauque,1,3 E. Chiffoleau,1,3 S. Brouard.1,2

    1INSERM UMR 1064, Nantes, France; 2CHU de Nantes, ITUN, Nantes, France; 3Université de Nantes, Faculté de Médecine, Nantes, France.

    Whereas a B cell transcriptional profile has been recorded for operationally tolerant kidney graft patients, the role that B cells may play in this process…
  • 2015 American Transplant Congress

    Development of a Risk Assessment Model for HIV Among Increased Risk Deceased Donors With Negative Nucleic Acid Testing

    P. Annambhotla, B. Gurbaxani, M. Kuehnert, S. Basavaraju.

    Centers for Disease Control and Prevention, Atlanta, GA.

    Background: In 2013, guidelines for reducing the risk of HIV, hepatitis B and C disease transmission through organ transplants were released. These include criteria which…
  • 2015 American Transplant Congress

    Dendritic Cells in Kidney Transplant Biopsies Are Associated With Poor Allograft Survival

    I. Batal,1 S. De Serres,1 K. Safa,1 A. Waaga,1 M. Onozato,2 N. Najafian,1 A. Chandraker.1

    1Brigham and Women's Hospital/Harvard Medical School, Boston, MA; 2Massachusetts General Hospital/Harvard Medical School, Boston, MA.

    Background: Long-term renal allograft survival continues to lag behind the progress seen in short-term transplant outcomes. Dendritic cells (DCs) are the most efficient antigen-presenting cells,…
  • 2015 American Transplant Congress

    Changes in Health Related Quality of Life (HRQOL) in Pediatric Liver Transplant (LT) Recipients During Protocolized Immunosuppression Withdrawal (ISW): The iWITH Trial

    S. Mohammad,1 S. Sundaram,2 V. Venkat,3 M. Martinez,4 J. Lopez,5 J. Magee,5 E. Alonso,1 S. Feng.6

    1Northwestern U, Chicago; 2U of Colorado, Aurora; 3U of Pittsburgh, Pittsburgh; 4Columbia U., New York; 5U of Michigan, Ann Arbor; 6UCSF, San francisco.

    ISW may limit medication-related comorbidities but intensive monitoring and unexpected rejection episodes may compromise HRQOL. We studied longitudinal HRQOL in pediatric LT recipients undergoing ISW…
  • 2015 American Transplant Congress

    The Selection Process for Total Artificial Heart

    F. Arabia, L. Czer, M. Kittleson, E. Passano, F. Liou, J. Yabuno, H. Henry, D. Chang, F. Esmailian, J. Kobashigawa, J. Moriguchi.

    Cedars-Sinai Heart Institute, Los Angeles, CA.

    Purpose: Heart failure patients with severe biventricular failure who are candidates for heart transplant are considered for Total Artificial Heart (TAH) support. These patients may…
  • 2015 American Transplant Congress

    Failure to Account for Critical Candidate Characteristics Significantly Biases Kidney Transplant Center Report Cards Measuring Time to Transplant

    L. Kayler,1 J. Schold.2

    1Surgery, Montefiore Medical Center, Bronx, NY; 2Medicine, Cleveland Clinic, Cleveland, OH.

    Kidney transplant rate is proposed to be integrated into the new composite metric to evaluate center performance. Current methods adjust for PRA, blood type, re-transplantation,…
  • 2015 American Transplant Congress

    Matching Strategies in Kidney Paired Donation: A 7-Year Analysis of a Multi-Institutional Registry

    D. Fumo,1,2 L. Reece,2 S. Stepkowski,1 V. Kapoor,1 S. Rees,2 J. Kopke,2 M. Rees.1,2

    1University of Toledo Medical Center, Toledo, OH; 2Alliance for Paired Donation, Maumee, OH.

    Failure to convert computer-identified possible Kidney Paired Donation (KPD) exchanges into transplants has prevented KPD from reaching its full potential. The purpose of this study…
  • 2015 American Transplant Congress

    Negative Effects of Being Obese or Overweight on T Regulatory (Treg) Cell Suppressive Function in Patients Listed for Lung Transplantation (Tx)

    T. Akimova,1 J. Diamond,2 D. Wilkes,3 D. Lederer,4 J. Christie,2 W. Hancock.1

    1Path & Lab Med, CHOP & UPenn, Philadelphia; 2Pulm, Allergy & Crit Care Med, UPenn, Philadelphia; 3Med, Microbiol & Immunol, Indiana Uni Sch of Med & Thoracic Transplant Prog, Indianapolis; 4Medicine, Columbia Uni, New York.

    Aim: Obese and overweight patients may be prone to adverse outcomes following lung Tx. We sought to determine the relationship between body mass index (BMI)…
  • 2015 American Transplant Congress

    Ex Vivo Expansion With Rapamycin Enhances the Suppressive Function of Regulatory T Cells (Tregs) Isolated from Pediatric Thymus

    E. Dijke,1,2,3 R. Hoeppli,3,4 T. Ellis,1,2 J. Pearcey,1,2 I. Larsen,1,2 I. Rebeyka,1,2 D. Ross,1,2 M. Levings,3,4 L. West.1,2,3

    1University of Alberta, Edmonton, AB, Canada; 2Alberta Transplant Institute, Edmonton, AB, Canada; 3Canadian National Transplant Research Program, Edmonton/Vancouver, AB/BC, Canada; 4University of British Columbia, Vancouver, BC, Canada.

    INTRODUCTION: Treg-based cellular therapy to suppress graft-directed immunity could reduce the need for life-long immunosuppressive drugs. Challenges include isolation and expansion of pure Tregs to…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences